EY Strategy and Consulting Completes Support for Japan's Genomic Medicine Initiative

EY Strategy and Consulting (EYSC), based in Chiyoda, Tokyo, has recently wrapped up its provision of support for the Japan Genomic Medicine Initiative (GeMJ). Under the guidance of the Ministry of Health, Labour and Welfare, GeMJ was established to enhance the integration of research, diagnostics, and drug development through comprehensive genomic analysis, ultimately aiming to promote high-quality medical care among the Japanese public.

GeMJ plays a critical role in the integration, management, and effective utilization of genomic data, establishing a robust foundation for its associated activities. EYSC was actively involved from the early planning stages of this initiative, aiding in the alignment of stakeholders' perspectives and the development of the operational framework necessary to implement the project effectively.

Following the establishment of GeMJ, EYSC focused on several key areas to ensure smooth operational support:

- Coordinating and managing progress among stakeholders to foster seamless collaboration between various functions such as data analysis, utilization, and patient feedback.
- Structuring and enhancing discussions relating to operational processes and data utilization across different sectors.
- Organizing challenges and streamlining operational processes to construct an integrated governance model, which encompasses a variety of stakeholders.

With this assistance now completed, EYSC has effectively contributed to the early phases focused on establishing the operational foundation and framework for GeMJ.

EYSC's Involvement in the Healthcare and Pharmaceutical Sector

In its endeavors, EYSC has consistently focused on the healthcare and pharmaceutical sectors, supporting a range of phases from concept development to operational management aimed at utilizing data effectively and implementing advanced medical technologies. The support extends beyond initial concept design and encompasses organizational operationalization, as well as the examination and management of information infrastructures. By progressively broadening its support scope, EYSC has engaged with various stakeholders involved in these projects.

Notably, in projects that span medical, research, and governmental domains, EYSC has taken on the essential role of facilitating stakeholder negotiations and consensus-building, particularly in navigating the complexities inherent in such extensive initiatives.

To tackle advanced domains like genomic medicine, EYSC assigns professionals with deep expertise in healthcare and data analysis. By engaging in long-term project involvement, they contribute to accumulating knowledge and establishing a stable executing framework, essential for ongoing advancements.

Additionally, EYSC leverages a unique integrated approach that combines strategy, operations, and technology, while forming partnerships with internal and external expert teams. This collaborative strategy allows EYSC to maintain a comprehensive support structure for the entire project, enabling impactful deployment of medical data utilization and advanced healthcare implementations.

Through these efforts, EYSC has built considerable knowledge and capabilities to provide holistic support from strategy formulation to execution in complex, large-scale projects that involve intersections among healthcare, research, and government.

Comments from EYSC’s Healthcare and Pharmaceutical Sector Representatives

In remarks made by Takashi Matsumoto, Partner, and Ryusei Kameya, Manager, they emphasized the importance of combining appropriate team configurations, relationship building, and specialized knowledge to provide comprehensive support in navigating the complexities of this project. They reiterated their commitment to continue these efforts to enhance client value and achieve their objectives.

About EY

EY is committed to creating new value for clients, its members, society, and the planet, aiming to build a better world through instilling trust in capital markets. By harnessing data, AI, and advanced technology, EY teams assist clients in confidently shaping their futures while delivering solutions to pressing current and future challenges. EY's activities encompass all areas of assurance, consulting, tax, strategy, and transactions, supported by accumulated industry knowledge, diverse ecosystems, and global networks across more than 150 countries and regions.

EY Consulting Services

EY Consulting is dedicated to transforming businesses through the power of people, technology, and innovation. With over 70,000 consultants worldwide, EY aims to become world-class in transformational services. This commitment focuses on creating long-term value for people, clients, and society. Learn more at ey.com/consulting.